Campbell Joyner

19.8k total citations · 3 hit papers
31 papers, 11.7k citations indexed

About

Campbell Joyner is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Campbell Joyner has authored 31 papers receiving a total of 11.7k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Cardiology and Cardiovascular Medicine, 7 papers in Surgery and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Campbell Joyner's work include Cardiac Valve Diseases and Treatments (9 papers), Acute Myocardial Infarction Research (8 papers) and Antiplatelet Therapy and Cardiovascular Diseases (7 papers). Campbell Joyner is often cited by papers focused on Cardiac Valve Diseases and Treatments (9 papers), Acute Myocardial Infarction Research (8 papers) and Antiplatelet Therapy and Cardiovascular Diseases (7 papers). Campbell Joyner collaborates with scholars based in Canada, Poland and France. Campbell Joyner's co-authors include Stuart J. Connolly, Salim Yusuf, Denis Xavier, Basil S. Lewis, John W. Eikelboom, Lars Wallentin, Hans‐Christoph Diener, Rafael Díaz, Janice Pogue and Marco Alings and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Annals of Internal Medicine.

In The Last Decade

Campbell Joyner

31 papers receiving 11.2k citations

Hit Papers

Dabigatran versus Warfarin in Patients wi... 1991 2026 2002 2014 2009 2011 1991 2.5k 5.0k 7.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Campbell Joyner Canada 21 10.2k 4.5k 1.8k 1.7k 1.5k 31 11.7k
Scott D. Berkowitz United States 54 13.6k 1.3× 8.8k 1.9× 1.9k 1.1× 916 0.5× 3.3k 2.2× 195 17.0k
Alexander G.G. Turpie Canada 40 6.8k 0.7× 5.8k 1.3× 836 0.5× 567 0.3× 2.6k 1.7× 114 8.7k
Cecilia Becattini Italy 45 5.3k 0.5× 6.8k 1.5× 1.3k 0.7× 912 0.5× 1.9k 1.2× 209 8.6k
Joaquin E. Cigarroa United States 29 14.4k 1.4× 2.7k 0.6× 1.8k 1.0× 1.1k 0.6× 1.8k 1.2× 99 15.9k
Pieter W. Kamphuisen Netherlands 57 5.4k 0.5× 6.5k 1.4× 1.3k 0.7× 899 0.5× 1.9k 1.3× 230 10.9k
Scott C. Woller United States 31 3.5k 0.3× 5.1k 1.1× 950 0.5× 866 0.5× 1.8k 1.2× 103 7.3k
Eugenia Nikolsky United States 47 9.3k 0.9× 2.0k 0.4× 1.7k 0.9× 3.2k 1.9× 4.9k 3.3× 131 14.4k
Paul Reilly United States 42 15.7k 1.5× 7.8k 1.7× 2.4k 1.3× 704 0.4× 1.2k 0.8× 128 17.5k
Susan Chrolavicius Canada 24 5.9k 0.6× 1.9k 0.4× 430 0.2× 1.4k 0.8× 2.7k 1.8× 31 7.1k
Jonas Oldgren Sweden 48 19.5k 1.9× 8.3k 1.8× 2.8k 1.6× 739 0.4× 1.7k 1.2× 196 21.5k

Countries citing papers authored by Campbell Joyner

Since Specialization
Citations

This map shows the geographic impact of Campbell Joyner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Campbell Joyner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Campbell Joyner more than expected).

Fields of papers citing papers by Campbell Joyner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Campbell Joyner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Campbell Joyner. The network helps show where Campbell Joyner may publish in the future.

Co-authorship network of co-authors of Campbell Joyner

This figure shows the co-authorship network connecting the top 25 collaborators of Campbell Joyner. A scholar is included among the top collaborators of Campbell Joyner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Campbell Joyner. Campbell Joyner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bossard, Matthias, Salim Yusuf, David P. Faxon, et al.. (2019). 2387Recurrent cardiovascular events and mortality in relation to antiplatelet therapy in patients with myocardial infarction without obstructive coronary artery disease (MINOCA). European Heart Journal. 40(Supplement_1). 5 indexed citations
2.
Diener, Hans‐Christoph, John W. Eikelboom, Stuart J. Connolly, et al.. (2012). Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial. The Lancet Neurology. 11(3). 225–231. 128 indexed citations
3.
Jolly, Sanjit S., Salim Yusuf, John A. Cairns, et al.. (2011). Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. The Lancet. 377(9775). 1409–1420. 1374 indexed citations breakdown →
4.
Pasian, Sergio, et al.. (2010). Giant right coronary artery aneurysm on 64-MDCT. Journal of Cardiovascular Medicine. 11(7). 544–546. 2 indexed citations
5.
Cohen, Gideon, Brandon Zagorski, George T. Christakis, et al.. (2010). Are stentless valves hemodynamically superior to stented valves? Long-term follow-up of a randomized trial comparing Carpentier–Edwards pericardial valve with the Toronto Stentless Porcine Valve. Journal of Thoracic and Cardiovascular Surgery. 139(4). 848–859. 35 indexed citations
6.
Jassal, Davinder S., James W. Tam, Randall A. Sochowski, et al.. (2009). Association of Bicuspid Aortic Valve Morphology and Aortic Root Dimensions: A Substudy of the Aortic Stenosis Progression Observation Measuring Effects of Rosuvastatin (ASTRONOMER) Study. Echocardiography. 27(2). 174–179. 23 indexed citations
7.
Jolly, Sanjit S., David P. Faxon, Keith A.A. Fox, et al.. (2009). Efficacy and Safety of Fondaparinux Versus Enoxaparin in Patients With Acute Coronary Syndromes Treated With Glycoprotein IIb/IIIa Inhibitors or Thienopyridines. Journal of the American College of Cardiology. 54(5). 468–476. 46 indexed citations
8.
Joyner, Campbell, Ron Peters, Rizwan Afzal, et al.. (2009). Fondaparinux compared to enoxaparin in patients with acute coronary syndromes without ST-segment elevation: Outcomes and treatment effect across different levels of risk. American Heart Journal. 157(3). 502–508. 23 indexed citations
9.
Budaj, Andrzej, John W. Eikelboom, R. Afzal, et al.. (2008). Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes. European Heart Journal. 30(6). 655–661. 127 indexed citations
10.
Jassal, Davinder S., James W. Tam, Isabelle Gaboury, et al.. (2008). Association of mitral annular calcification and aortic valve morphology: a substudy of the aortic stenosis progression observation measuring effects of rosuvastatin (ASTRONOMER) study. European Heart Journal. 29(12). 1542–1547. 38 indexed citations
11.
Peters, Ron, Campbell Joyner, Jean‐Pierre Bassand, et al.. (2006). Abstract 3294: Fondaparinux versus Control (Placebo or Unfractionated Heparin) as an Adjunct to Thrombolytic Therapy in Acute Myocardial Infarction: an OASIS 6 Substudy. 114. 3 indexed citations
12.
Anand, Sonia S., Shamir R. Mehta, Maria Grazia Franzosi, et al.. (2005). Differences in the Management and Prognosis of Women and Men Who Suffer From Acute Coronary Syndromes. Journal of the American College of Cardiology. 46(10). 1845–1851. 225 indexed citations
13.
Hanayama, Naoji, George T. Christakis, Hari R. Mallidi, et al.. (2005). Determinants of Incomplete Left Ventricular Mass Regression Following Aortic Valve Replacement for Aortic Stenosis. Journal of Cardiac Surgery. 20(4). 307–313. 34 indexed citations
14.
Cohen, Gideon, George T. Christakis, Campbell Joyner, et al.. (2002). Are stentless valves hemodynamically superior to stented valves? A prospective randomized trial. The Annals of Thoracic Surgery. 73(3). 767–778. 96 indexed citations
15.
Hanayama, Naoji, George T. Christakis, Hari R. Mallidi, et al.. (2002). Patient prosthesis mismatch is rare after aortic valve replacement: valve size may be irrelevant. The Annals of Thoracic Surgery. 73(6). 1822–1829. 140 indexed citations
16.
Oxorn, Donald C., Gerald Edelist, Bernard S. Goldman, & Campbell Joyner. (1999). Echocardiography and excision of lipomatous hypertrophy of the interatrial septum. The Annals of Thoracic Surgery. 67(3). 852–854. 8 indexed citations
17.
Cohen, Gideon, George T. Christakis, Karen J. Buth, et al.. (1997). Early experience with stentless versus stented valves.. PubMed. 96(9 Suppl). II–76. 26 indexed citations
18.
Reeves, Richard A., Frans H. H. Leenen, & Campbell Joyner. (1992). Reproducibility of nurse-measured, exercise and ambulatory blood pressure and echocardiographic left ventricular mass in borderline hypertension. Journal of Hypertension. 10(10). 1249–1256. 15 indexed citations
19.
Connolly, Stuart J., Andreas Laupacis, Michael Gent, et al.. (1991). Canadian atrial fibrillation anticoaguiation (CAFA) study. Journal of the American College of Cardiology. 18(2). 349–355. 831 indexed citations breakdown →
20.
Laupacis, Andreas, Stuart J. Connolly, Michael Gent, et al.. (1991). How Should Results from Completed Studies Influence Ongoing Clinical Trials?. Annals of Internal Medicine. 115(10). 818–822. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026